Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 08:38:24 +0200Tue, 21 May 2024 16:40:00 +0200Human medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 13, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/erleadaHuman medicines European public assessment report (EPAR): Erleada, apalutamide, Date of authorisation: 14/01/2019, Revision: 13, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/erleadaTue, 21 May 2024 16:40:00 +0200Human medicineErleada : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4452-en_1.pdfErleada : EPAR - Product informationhttps://www.ema.europa.eu/system/files/documents/product-information/ema-combined-h-4452-en_1.pdfTue, 21 May 2024 14:26:00 +0200Human medicine